JP2014237722A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014237722A5 JP2014237722A5 JP2014190642A JP2014190642A JP2014237722A5 JP 2014237722 A5 JP2014237722 A5 JP 2014237722A5 JP 2014190642 A JP2014190642 A JP 2014190642A JP 2014190642 A JP2014190642 A JP 2014190642A JP 2014237722 A5 JP2014237722 A5 JP 2014237722A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- content
- total amount
- respect
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims 2
- KKEMWYNNTBRYMR-UHFFFAOYSA-N azulene-1-sulfonic acid Chemical compound C1=CC=CC=C2C(S(=O)(=O)O)=CC=C21 KKEMWYNNTBRYMR-UHFFFAOYSA-N 0.000 claims 2
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 claims 2
- 229960003291 chlorphenamine Drugs 0.000 claims 2
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims 2
- 229960004949 glycyrrhizic acid Drugs 0.000 claims 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims 2
- 239000001685 glycyrrhizic acid Substances 0.000 claims 2
- 235000019410 glycyrrhizin Nutrition 0.000 claims 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims 2
- 229940067606 lecithin Drugs 0.000 claims 2
- 235000010445 lecithin Nutrition 0.000 claims 2
- 239000000787 lecithin Substances 0.000 claims 2
- 229940041616 menthol Drugs 0.000 claims 2
- 229960002362 neostigmine Drugs 0.000 claims 2
- LULNWZDBKTWDGK-UHFFFAOYSA-M neostigmine bromide Chemical compound [Br-].CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 LULNWZDBKTWDGK-UHFFFAOYSA-M 0.000 claims 2
- 229960003471 retinol Drugs 0.000 claims 2
- 235000020944 retinol Nutrition 0.000 claims 2
- 239000011607 retinol Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 229960001295 tocopherol Drugs 0.000 claims 2
- 229930003799 tocopherol Natural products 0.000 claims 2
- 235000010384 tocopherol Nutrition 0.000 claims 2
- 239000011732 tocopherol Substances 0.000 claims 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 2
- 239000006172 buffering agent Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014190642A JP5879410B2 (ja) | 2014-09-19 | 2014-09-19 | コンタクトレンズ用眼科組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014190642A JP5879410B2 (ja) | 2014-09-19 | 2014-09-19 | コンタクトレンズ用眼科組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010123389A Division JP5627294B2 (ja) | 2010-05-28 | 2010-05-28 | コンタクトレンズ用眼科組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016013456A Division JP2016056213A (ja) | 2016-01-27 | 2016-01-27 | コンタクトレンズ用眼科組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014237722A JP2014237722A (ja) | 2014-12-18 |
| JP2014237722A5 true JP2014237722A5 (https=) | 2015-07-02 |
| JP5879410B2 JP5879410B2 (ja) | 2016-03-08 |
Family
ID=52135151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014190642A Active JP5879410B2 (ja) | 2014-09-19 | 2014-09-19 | コンタクトレンズ用眼科組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5879410B2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7324566B2 (ja) * | 2015-05-28 | 2023-08-10 | ロート製薬株式会社 | 水性眼科組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62106018A (ja) * | 1985-11-01 | 1987-05-16 | Santen Pharmaceut Co Ltd | 高濃度ビタミンe水性製剤 |
| JPH06340525A (ja) * | 1993-06-02 | 1994-12-13 | Lion Corp | 安定な低眼刺激性ビタミンa類可溶化点眼剤 |
| JP3442168B2 (ja) * | 1994-11-30 | 2003-09-02 | 旭化成アイミー株式会社 | ケア用品 |
| DE69521717T2 (de) * | 1994-12-19 | 2001-10-31 | Taisho Pharmaceutical Co., Ltd. | Augentropfen mit liposomen |
| JP2000319170A (ja) * | 1999-03-05 | 2000-11-21 | Eisai Co Ltd | テプレノン含有点眼剤 |
| KR101188156B1 (ko) * | 2003-09-10 | 2012-10-05 | 센주 세이야꾸 가부시키가이샤 | 콘택트렌즈용 안과용 조성물 |
| JP4776282B2 (ja) * | 2004-06-24 | 2011-09-21 | ロート製薬株式会社 | コンタクトレンズ用組成物 |
| JP5340954B2 (ja) * | 2007-11-16 | 2013-11-13 | テクノガード株式会社 | 薬物含有脂肪乳剤およびその製造方法 |
| JP5616589B2 (ja) * | 2008-05-29 | 2014-10-29 | ロート製薬株式会社 | 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
| JP5568246B2 (ja) * | 2008-06-04 | 2014-08-06 | ロート製薬株式会社 | 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤 |
-
2014
- 2014-09-19 JP JP2014190642A patent/JP5879410B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2015003117A1 (es) | Modificaciones en la estructura cristalina | |
| DOP2018000297A (es) | Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo | |
| ES2556585T3 (es) | Composiciones que comprenden sulfato de salbutamol | |
| AR088381A1 (es) | Formulaciones de etanercept estabilizadas con meglumina | |
| WO2014153009A3 (en) | Thiosaccharide mucolytic agents | |
| BR112015017405A2 (pt) | composições que incluem agentes hidrofobizantes e estabilizantes e métodos para preparação e utilização das mesmas | |
| EA201501032A1 (ru) | Фармацевтическая композиция, способы лечения и ее применения | |
| CO2017006898A2 (es) | Formulación de relación fija de insulina glargina/lixisenatida | |
| BR112017007460A2 (pt) | inibidores de di-hidropirrolopiridina de ror-gama | |
| BR112015022191A2 (pt) | compostos heteroarila, seu uso e composição que os compreende | |
| BR112016008576A2 (pt) | Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária | |
| AR128816A2 (es) | Formas de dosificación farmacéutica de perlas de cisteamina | |
| MX2016007278A (es) | Metodos y composiciones farmaceuticas para la expresion de un polinucleotido de interes en el epitelio pigmentario retiniano de un sujeto. | |
| MX2018003893A (es) | Moduladores del receptor p2x3 y p2x2/3 de diaminopirimidina para usarse en el tratamiento de la tos. | |
| BR112016011170A8 (pt) | derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica | |
| CL2016000026A1 (es) | Nuevos derivados de azabencimidazol | |
| EA201591950A1 (ru) | Лекарственная форма в виде пленки, содержащей свободное основание тадалафила, содержащая полимер на основе полиэтиленгликоля и/или полимер на основе винилпирролидона в качестве агента, стабилизирующего дисперсию | |
| UA110979C2 (uk) | Рідка фармацевтична композиція, яка включає нітизинон | |
| HK1203772A1 (en) | Liquid tobacco compositions | |
| ECSP16058769A (es) | Composicion para la administracion oral de agente bioactivos | |
| HK1216839A1 (zh) | 调整释放制剂 | |
| MX384303B (es) | Composiciones y métodos para metabolismo muscular mejorado. | |
| AR100028A1 (es) | Composiciones nutricionales que contienen ácido estearidónico | |
| JP2014237722A5 (https=) | ||
| EP2958891A4 (en) | RED FLUORESCENT ALDEHYDE DEHYDROGENASE (ALDH) SUBSTRATE |